Fisher & Paykel Healthcare Corporation Limited (FSPKF)
USD 16.35
(-25.78%)
USD 16.35
(-25.78%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 1.04 Billion NZD | 12.03% |
| 2023 | 945.9 Million NZD | -6.66% |
| 2022 | 1.01 Billion NZD | -17.11% |
| 2021 | 1.22 Billion NZD | 44.6% |
| 2020 | 845.5 Million NZD | 17.84% |
| 2019 | 717.5 Million AUD | 13.15% |
| 2018 | 634.1 Million AUD | 12.13% |
| 2017 | 565.52 Million AUD | 7.79% |
| 2016 | 524.65 Million AUD | 37.11% |
| 2015 | 382.64 Million AUD | 23.21% |
| 2014 | 310.55 Million AUD | 19.98% |
| 2013 | 258.84 Million AUD | 15.0% |
| 2012 | 225.07 Million AUD | -5.95% |
| 2011 | 239.3 Million AUD | -1.44% |
| 2010 | 242.81 Million AUD | -11.2% |
| 2009 | 273.42 Million AUD | 62.61% |
| 2008 | 168.15 Million AUD | -15.98% |
| 2007 | 200.14 Million AUD | 19.01% |
| 2006 | 168.18 Million AUD | -3.28% |
| 2005 | 173.89 Million AUD | 14.2% |
| 2004 | 152.27 Million AUD | 8.11% |
| 2003 | 140.85 Million AUD | -4.47% |
| 2002 | 147.44 Million AUD | -23.54% |
| 2001 | 192.84 Million AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | 279.15 Million NZD | 0.0% |
| 2024 Q2 | 498.2 Million NZD | 104.98% |
| 2024 Q3 | 279.15 Million NZD | -43.97% |
| 2024 FY | 1.05 Billion NZD | 12.03% |
| 2024 Q1 | 243.05 Million NZD | -54.04% |
| 2023 Q1 | 206.6 Million NZD | -55.67% |
| 2023 Q2 | 417.1 Million NZD | 101.89% |
| 2023 Q4 | 528.8 Million NZD | 101.37% |
| 2023 FY | 945.9 Million NZD | -6.66% |
| 2023 Q3 | 262.6 Million NZD | -37.04% |
| 2022 Q4 | 466.1 Million NZD | 92.21% |
| 2022 Q1 | 283.85 Million NZD | -57.01% |
| 2022 FY | 1.01 Billion NZD | -17.11% |
| 2022 Q2 | 547.3 Million NZD | 92.81% |
| 2022 Q3 | 242.5 Million NZD | -55.69% |
| 2021 Q1 | 280.95 Million NZD | -38.82% |
| 2021 Q3 | 341.85 Million NZD | -39.21% |
| 2021 Q4 | 660.29 Million NZD | 93.15% |
| 2021 FY | 1.22 Billion NZD | 44.6% |
| 2021 Q2 | 562.3 Million NZD | 100.14% |
| 2020 Q1 | 191.45 Million NZD | 2.32% |
| 2020 Q4 | 459.2 Million NZD | 102.78% |
| 2020 Q3 | 226.45 Million NZD | -41.38% |
| 2020 FY | 845.5 Million NZD | 17.84% |
| 2020 Q2 | 386.3 Million NZD | 101.78% |
| 2019 FY | 717.5 Million AUD | 13.15% |
| 2019 Q4 | 187.1 Million NZD | 0.0% |
| 2019 Q3 | 187.1 Million NZD | 9.54% |
| 2019 Q2 | 170.8 Million NZD | 0.0% |
| 2019 Q1 | 170.8 Million NZD | -1.75% |
| 2018 Q3 | 173.85 Million NZD | 14.87% |
| 2018 FY | 634.1 Million AUD | 12.13% |
| 2018 Q1 | 151.35 Million NZD | -3.75% |
| 2018 Q2 | 151.35 Million NZD | 0.0% |
| 2018 Q4 | 173.85 Million NZD | 0.0% |
| 2017 Q1 | 137.95 Million NZD | -1.62% |
| 2017 FY | 565.52 Million AUD | 7.79% |
| 2017 Q4 | 157.25 Million NZD | 0.0% |
| 2017 Q3 | 157.25 Million NZD | 13.99% |
| 2017 Q2 | 137.95 Million NZD | 0.0% |
| 2016 Q4 | 140.21 Million NZD | 0.0% |
| 2016 Q3 | 140.21 Million NZD | 16.26% |
| 2016 Q2 | 120.6 Million NZD | 0.0% |
| 2016 Q1 | 120.6 Million NZD | 10.26% |
| 2016 FY | 524.65 Million AUD | 37.11% |
| 2015 Q1 | 96.1 Million NZD | 2.34% |
| 2015 Q3 | 109.38 Million NZD | 13.81% |
| 2015 Q4 | 109.38 Million NZD | 0.0% |
| 2015 FY | 382.64 Million AUD | 23.21% |
| 2015 Q2 | 96.1 Million NZD | 0.0% |
| 2014 Q1 | 88.79 Million NZD | 9.03% |
| 2014 FY | 310.55 Million AUD | 19.98% |
| 2014 Q3 | 93.9 Million NZD | 5.75% |
| 2014 Q2 | 88.79 Million NZD | 0.0% |
| 2014 Q4 | 93.9 Million NZD | 0.0% |
| 2013 Q4 | 81.44 Million NZD | 0.0% |
| 2013 Q3 | 81.44 Million NZD | 0.0% |
| 2013 FY | 258.84 Million AUD | 15.0% |
| 2012 FY | 225.07 Million AUD | -5.95% |
| 2011 FY | 239.3 Million AUD | -1.44% |
| 2010 FY | 242.81 Million AUD | -11.2% |
| 2009 FY | 273.42 Million AUD | 62.61% |
| 2008 FY | 168.15 Million AUD | -15.98% |
| 2007 FY | 200.14 Million AUD | 19.01% |
| 2006 FY | 168.18 Million AUD | -3.28% |
| 2005 FY | 173.89 Million AUD | 14.2% |
| 2004 FY | 152.27 Million AUD | 8.11% |
| 2003 FY | 140.85 Million AUD | -4.47% |
| 2002 FY | 147.44 Million AUD | -23.54% |
| 2001 FY | 192.84 Million AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | -61367.583% |
| Ansell Limited | 624.8 Million USD | -67.157% |
| Ansell Limited | 624.8 Million USD | -67.157% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 113.94 Million USD | -816.607% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -773214.576% |
| Psykey, Inc. | 415.97 Thousand USD | -250972.177% |
| ConvaTec Group Plc | 1.2 Billion USD | 13.191% |
| ConvaTec Group Plc | 1.17 Billion USD | 11.1% |
| Encision Inc. | 3.13 Million USD | -33203.975% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 794.01 Thousand USD | -131434.37% |
| LifePoint, Inc. | -71.35 Thousand USD | 1463706.043% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 797351.908% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | -198833.333% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | -173031.755% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | -175011.205% |
| SmileDirectClub, Inc. | 275.84 Million USD | -278.616% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | -15.951% |
| SheerVision, Inc. | 2.17 Million USD | -47898.331% |
| United Health Products, Inc. | -4857.00 USD | 21503085.382% |
| Vasamed, Inc. | -69.38 Thousand USD | 1505259.394% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | -390092.145% |
| Yubo International Biotech Limited | 52.65 Thousand USD | -1983490.367% |